Male Birth Control: A Game Changer

Although Big Pharma has shown little interest in developing male birth control, scientists continue to forge ahead with numerous new contraceptive techniques, including one that may start human trials within the next year.

If successful, those innovations could cut into half of Big Pharma’s existing profits—today, the market for female contraceptives is $10 billion and condom sales are $3.2 billion annually.

Yet drug makers remain reluctant, some citing marketing obstacles, despite avowed male interest in contraceptives. In 2000, 83% of men surveyed across countries said they’d take a contraceptive. Meanwhile, Big Pharma’s hesitancy has left small companies to seek funding and grants from large public health funders like the WHO or smaller non-profits.

Source: CNBC

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top